Skip to main content
Home
Resources for Cancer Researchers
Patients & Families Link
  • Patients & Caregivers
  • About
    • History
    • Leadership
  • Administration
    • Cancer Researchers' Toolkit
      • Federal Grants Assistance
      • Finding Funding
      • Funding Sources
    • Grants & Contracts Team
  • Research Programs
    • Experimental Therapeutics
    • Hormone Related Cancers
    • Molecular and Structural Biology
    • Population Science
    • Tumor Immunology and Immunotherapy
  • Clinical Research
    • Clinical Research Management Office
    • Scientific and Safety Review
  • Shared Resources
    • Biostatistics
      • Personnel
      • Policies, Fees and Initiating Services
      • Services
    • FACT Lab
    • Flow Cytometry
      • Facilities Utilization
      • Instrumentation
      • Analysis and Training Fees
      • Useful Links
    • Genomics
      • Common Use Equipment
      • Ordering
      • Personnel
      • Services
        • Bioinformatics Support for Data Analysis
        • Custom Low- to Mid-Plex Genotyping
        • DNA Sequencing
        • DNA/RNA Synthesis
        • Gene Expression Arrays
        • Genotyping Arrays
        • Miscellaneous Array-Based Assays
        • Peptide Synthesis
        • Peptide/Protein Characterization
        • Taqman Genotyping
    • Imaging
      • Xenogen Instrument
    • Pathology and Biorepository
      • Services
    • Structural Biology
    • Translational Laboratory
      • Facilities and Equipment
      • Ordering
      • Services
      • Support of Clinical Trials
  • Training & Education
    • Middle & High School Programs
      • STEM Outreach Day
      • UMB CURE Scholars
      • CATALYST
      • RAMP
    • Summer Undergraduate Research Programs
      • Nathan Schnaper Intern Program in Translational Cancer Research (NSIP)
        • Appreciation of Support
        • Meet the Program Director
        • Eligibility and Compensation
        • History and Program Setting
          • About Dr. Nathan Schnaper
        • How to Apply and Important Dates
        • Training Components and Activities
    • Post-baccalaureate: STAR-PREP
    • Graduate Training & Education
    • Predoctoral T32 Training Program in Cancer Biology
    • Postdoctoral T32 Training Program in Cancer Biology
    • Postdoctoral Training
      • How to Apply
      • Postdoctoral T32 Training Program in Cancer Biology
      • Research Training Programs
    • Clinical Residency / Fellowship
    • American Cancer Society Institutional Research Grants
      • Recent ACS Grant Awardees
    • Continuing Medical Education
    • Radiation Therapy Training Program
    • Steering Committee
    • T32 Cancer Biology Training Grant
      • Cancer Biology T32 Training Grant
        • Applications
        • Faculty Mentor Requirements
      • Mentors - T32 Cancer Biology
  • Community Outreach
    • COE Home
    • Partnerships
    • Research Projects
    • Team
    • Cancer InFocus
  • Funding Opportunities
    • Weekly Research Newsletter
  • Events Calendar
    • 23rd Annual Research Matters Conference
    • 15th Annual Cancer Biology Research Retreat
  • Newsroom
    • Share PR Updates
  • Cancer InFocus

Breadcrumb

  1. Home
  2. Newsroom
  • Photo of Lei Ren, PhD
    Lei Ren, PhD
    March 4, 2025
    Innovative CT Scan Technique Could Improve Prognosis and Treatments for Head and Neck Cancers, New Research Suggests
    Data collected in pre-treatment CT-scans may provide important imaging biomarkers to better predict patient prognosis, and potentially customize treatment strategies
  • Taofeek K. Owonikoko, MD, PhD
    Taofeek K. Owonikoko, MD, PhD
    February 20, 2025
    UM Greenebaum Comprehensive Cancer Center Executive Director, Taofeek K. Owonikoko, MD, PhD, named one of the 25 Black Marylanders to Watch by The Baltimore Sun
    Taofeek K. Owonikoko, MD, PhD, Executive Director of the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center (UMGCCC), has been named one of the 25 Black Marylanders to Watch for 2025 by The Baltimore Sun.
  • Jeremy L. Davis, MD
    Jeremy L. Davis, MD
    January 15, 2025
    Jeremy L. Davis, MD, Named UMGCCC Surgical Oncology Lead and Chief of the Division of Surgical Oncology at UMSOM
    University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center (UMGCCC) Executive Director, Taofeek K. Owonikoko, MD, PhD, and University of Maryland School of Medicine (UMSOM) Department of Surgery Chair, Christine Lau, MD, MBA, have announced that Jeremy L. Davis, MD, will serve as the new Surgical Oncology Lead for UMGCCC and Chief of the Division of Surgical Oncology in the Department of Surgery at UMSOM. Dr. Davis is a nationally recognized surgical oncologist and leader in gastric cancer research.

Contact

Katie Ghiardi
Lead Media & Public Relations Specialist
University of Maryland Marlene and Stewart Greenebaum
Comprehensive Cancer Center
KGhiardi@som.umaryland.edu

Share PR Updates 

 

UMGCCC in the Media

  • Black Marylanders to Watch 2025: Dr. Taofeek Kunle Owonikoko (The Baltimore Sun)
  • Proactive ways to reduce your risk for cancer (Fox45News Morning Show)
  • Surgeon general issues advisory on link between alcohol and cancer (Scripps New…
  • Prince George's County woman battles harrowing rare cancer most would not have …
  • LUTH has partnered with UMSOM on capacity building, research and treatment of n…

In Partnership with the University of Maryland School of Medicine

Need to update content? Contact the Webmaster .

© 2025 All rights reserved. University of Maryland Greenebaum Comprehensive Cancer Center (UMGCCC). 22 S. Greene Street, Baltimore, MD 21201.